Literature DB >> 12073046

Immunohistochemical study of the expression of cell cycle regulating proteins at different stages of bladder cancer.

Hanne Primdahl1, Hans von der Maase, Flemming B Sørensen, Hans Wolf, Torben F Ørntoft.   

Abstract

PURPOSE: The cell cycle is known to be deregulated in cancer. We therefore analyzed the expression of the cell cycle related proteins p21, p27, p16, Rb, and L-myc by immunohistochemical staining of bladder tumors.
METHODS: The tissue material consisted of bladder tumors from three groups of patients; group 1, 23 patients with recurrent stage Ta (non-invasive) tumors; group 2, 22 patients presenting at their first admission with T2-4 (muscle invasive) tumors; group 3, 24 patients who experienced disease progression from Ta or T1 (invasive in connective tissue) to a higher stage. By immunohistochemical staining the protein expression was compared to allelic deletions of the corresponding genes. The allelic deletions were detected by PCR-based microsatellite analyses.
RESULTS: We detected a significant reduction in the expression levels of the cell cycle related proteins p21(waf1) ( P=0.002), p27(kip1) ( P=0.03), Rb ( P=0.00002), and L-myc ( P=0.00000007) in muscle invasive tumors compared to noninvasive tumors. Tumors presenting as muscle invasive at first diagnosis had significantly lower levels of p16/CDKN2A ( P=0.01) when compared to muscle invasive tumors that followed Ta or T1 precursor lesions. We found no general correlation between allelic deletion of a gene and its immunohistochemical protein expression, indicating that the remaining allele may be capable of encoding a normal or even increased protein level.
CONCLUSIONS: Our results support the hypothesis that bladder tumors with invasion at first diagnosis differ from those in which invasion follow superficial tumors. This difference is reflected as a different level in cell cycle related protein expression. The data also indicate that allelic deletions of cell cycle related genes do not correlate with an altered level of protein expression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12073046     DOI: 10.1007/s00432-002-0344-3

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  8 in total

1.  Do AB0 blood groups affect lower urinary tract symptoms?

Authors:  Erdal Benli; Abdullah Çırakoğlu; Ercan Öğreden; Yasemin Kaya; Ali Ayyıldız; Ahmet Yüce
Journal:  Turk J Urol       Date:  2018-11-19

2.  Prognostic value of cell cycle regulatory proteins in muscle-infiltrating bladder cancer.

Authors:  Fabia Galmozzi; Alessandra Rubagotti; Andrea Romagnoli; Giorgio Carmignani; Luisa Perdelli; Beatrice Gatteschi; Francesco Boccardo
Journal:  J Cancer Res Clin Oncol       Date:  2006-06-21       Impact factor: 4.553

3.  The impact of the AB0 and the Rhesus blood group system on outcomes in bladder cancer patients treated with radical cystectomy.

Authors:  Oliver Engel; Armin Soave; Sven Peine; Luis A Kluth; Marianne Schmid; Shahrokh F Shariat; Roland Dahlem; Margit Fisch; Michael Rink
Journal:  World J Urol       Date:  2015-03-18       Impact factor: 4.226

4.  Biomarkers in bladder cancer: present status and perspectives.

Authors:  Wun-Jae Kim; Soongang Park; Yong-June Kim
Journal:  Biomark Insights       Date:  2007-03-27

5.  Superficial bladder cancer: an update on etiology, molecular development, classification, and natural history.

Authors:  Erik Pasin; David Y Josephson; Anirban P Mitra; Richard J Cote; John P Stein
Journal:  Rev Urol       Date:  2008

6.  Phosphatidylinositol 3'-kinase, mTOR, and glycogen synthase kinase-3β mediated regulation of p21 in human urothelial carcinoma cells.

Authors:  Nicole L Yohn; Caitlyn N Bingaman; Ashley L DuMont; Lina I Yoo
Journal:  BMC Urol       Date:  2011-08-24       Impact factor: 2.264

Review 7.  Prognostic and Clinicopathological Significance of Downregulated p16 Expression in Patients with Bladder Cancer: A Systematic Review and Meta-Analysis.

Authors:  Xiaoning Gan; Xiaomiao Lin; Rongquan He; Xinggu Lin; Hanlin Wang; Liyan Yan; Hong Zhou; Hui Qin; Gang Chen
Journal:  Dis Markers       Date:  2016-04-20       Impact factor: 3.434

8.  PHLPP2 stabilization by p27 mediates its inhibition of bladder cancer invasion by promoting autophagic degradation of MMP2 protein.

Authors:  Minggang Peng; Jingjing Wang; Dongyun Zhang; Honglei Jin; Jingxia Li; Xue-Ru Wu; Chuanshu Huang
Journal:  Oncogene       Date:  2018-06-21       Impact factor: 9.867

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.